Indometacin Fiterman (Indometacin)

Indometacin blocks both cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, preventing the formation of prostaglandins that mediate inflammation, pain, and fever. By reducing prostaglandin synthesis, it diminishes the inflammatory response at the site of application.

The specific dose and frequency are determined by the prescribing healthcare professional based on the patient’s condition, severity, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the amount on their own.

Safety of indometacin in pregnancy and lactation has not been established. It is generally avoided, especially in the third trimester, because of potential risks to the fetus and newborn. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature‑controlled requirements) and the necessary import documentation.

Indometacin is a potent NSAID with strong anti‑inflammatory activity, often considered more effective for gout and certain severe arthritic conditions than ibuprofen or naproxen. However, its risk profile for gastrointestinal and renal adverse effects can be higher, so clinicians weigh efficacy against safety when selecting an NSAID for each patient.

The product should be stored at room temperature, below 25 °C, in its original packaging. It must be kept away from moisture, direct sunlight, and sources of heat. Ensure the container is tightly closed to maintain product integrity until use.

Indometacin Fiterman is applied topically to the affected skin area. The prescribed amount is spread thinly and gently massaged into the skin, usually 2–4 times daily, or as directed by the prescriber. Hands should be washed before and after application.

Serious risks include severe allergic reactions (anaphylaxis), life‑threatening skin conditions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, gastrointestinal bleeding or ulceration, acute kidney injury, and significant liver enzyme elevations. Any signs of these conditions require immediate medical attention.

Individuals with known hypersensitivity to indometacin or other NSAIDs, those with active gastrointestinal ulceration, severe renal or hepatic impairment, uncontrolled hypertension, or a history of cardiovascular thrombotic events should avoid using this product. Pregnant women, especially in the third trimester, should also refrain from use.